Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.

Orban, M; Mayer, K; Morath, T; Bernlochner, I; Hadamitzky, M; Braun, S; Schulz, S; Hoppmann, P; Hausleiter, J; Tiroch, K; Mehilli, J; Schunkert, H; Massberg, S; Laugwitz, K-L; Sibbing, D; Kastrati, A

Orban, M; Mayer, K; Morath, T; Bernlochner, I; Hadamitzky, M; Braun, S; Schulz, S; Hoppmann, P; Hausleiter, J; Tiroch, K; Mehilli, J; Schunkert, H; Massberg, S; Laugwitz, K-L; Sibbing, D; Kastrati, A.

Affiliation

Orban M; Martin Orban, MD, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Campus Großhadern, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377 München, Germany, Tel.: +49 89 7095 2361, Fax: +49 89 7095 8830, E-mail: MartinOrban@gmail.com.
Mayer K; Katharina Mayer, MD, Deutsches Herzzentrum München, Lazarettstr. 36, 80636 Munich, Germany, Tel: +49 89 1218 0, Fax: +49 89 1218 4013, E-mail: katharina.mayer.mt@gmx.de.

Thromb Haemost ; 112(6): 1190-7, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25183544

Subject(s)

Blood Platelets/drug effects; Myocardial Infarction/therapy; Percutaneous Coronary Intervention; Piperazines/therapeutic use; Platelet Aggregation Inhibitors/therapeutic use; Purinergic P2Y Receptor Antagonists/therapeutic use; Receptors, Purinergic P2Y12/drug effects; Shock, Cardiogenic/etiology; Thiophenes/therapeutic use; Ticlopidine/analogs & derivatives; Aged; Aged, 80 and over; Blood Platelets/metabolism; Clopidogrel; Coronary Thrombosis/blood; Coronary Thrombosis/etiology; Coronary Thrombosis/prevention & control; Female; Germany; Hemorrhage/chemically induced; Humans; Male; Middle Aged; Myocardial Infarction/blood; Myocardial Infarction/complications; Myocardial Infarction/diagnosis; Myocardial Infarction/mortality; Percutaneous Coronary Intervention/adverse effects; Percutaneous Coronary Intervention/mortality; Piperazines/adverse effects; Platelet Aggregation Inhibitors/adverse effects; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists/adverse effects; Receptors, Purinergic P2Y12/blood; Recurrence; Registries; Risk Factors; Shock, Cardiogenic/blood; Shock, Cardiogenic/diagnosis; Shock, Cardiogenic/mortality; Thiophenes/adverse effects; Ticlopidine/adverse effects; Ticlopidine/therapeutic use; Time Factors; Treatment Outcome

Key words

Clopidogrel; bleeding; cardiogenic shock; mortality; prasugrel

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Piperazines / Shock, Cardiogenic / Thiophenes / Blood Platelets / Ticlopidine / Platelet Aggregation Inhibitors / Receptors, Purinergic P2Y12 / Purinergic P2Y Receptor Antagonists / Percutaneous Coronary Intervention / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Country/Region as subject: Europa Language: En Journal: Thromb Haemost Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google